APO TP 25 Pill - white round, 4mm
Pill with imprint APO TP 25 is White, Round and has been identified as Topiramate 25 mg. It is supplied by Apotex Corp.
Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Seizure Prevention; Epilepsy; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO TP 25



Topiramate
- Imprint
- APO TP 25
- Strength
- 25 mg
- Color
- White
- Size
- 4.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
hydroxypropyl cellulose,
hypromellose 2910 (5 mPa.s),
magnesium stearate,
methylcellulose (15 mPa.s),
polyethylene glycol 8000,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
60505-2760 (Discontinued) | Apotex Corp. |
60429-0769 (Discontinued) | Golden State Medical Supply (repackager) |
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,332)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
- Topiramate drug information
- Topiramate Extended-Release Capsules
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Sprinkle Capsules
Other brands
Topamax, Trokendi XR, Eprontia, Topiragen, Qudexy XR
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.